doxorubicin hydrochloride has been researched along with curcumin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, DD; Sahu, PK; Sahu, PL | 1 |
| Sahu, PK | 1 |
| Anil Kumar, NV; Rodrigues, FC; Thakur, G | 1 |
| Han, L; Huang, X; Jin, X; Li, X; Liang, B; Ouyang, F; Xu, Y; Yan, J; Zhan, M; Zhang, Q | 1 |
1 review(s) available for doxorubicin hydrochloride and curcumin
| Article | Year |
|---|---|
Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Curcumin; Humans; Molecular Structure | 2019 |
3 other study(ies) available for doxorubicin hydrochloride and curcumin
| Article | Year |
|---|---|
Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives.
Topics: Antioxidants; Cell Line, Tumor; Cell Survival; Curcumin; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; Oxidation-Reduction; Structure-Activity Relationship | 2016 |
Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Curcumin; Drug Design; Free Radical Scavengers; Humans; Nitric Oxide; Picrates; Structure-Activity Relationship | 2016 |
Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase; Tubulin; Tubulin Modulators | 2022 |